Unknown

Dataset Information

0

Inherited breast cancer predisposition in Asians: multigene panel testing outcomes from Singapore.


ABSTRACT: Genetic testing for germline mutations in breast cancer predisposition genes can potentially identify individuals at a high risk of developing breast and/or ovarian cancer. There is a paucity of such mutational information for Asians. Panel testing of 25 cancer susceptibility genes and BRCA1/2 deletion/duplication analysis was performed for 220 Asian breast cancer patients or their family members referred for genetics risk assessment. All 220 participants had at least one high-risk feature: having a family history of breast and/or ovarian cancer in first- and/or second-degree relatives; having breast and ovarian cancer in the same individual or bilateral breast cancer; having early-onset breast cancer or ovarian cancer (?40 years of age). We identified 67 pathogenic variants in 66 (30.0%) patients. Of these, 19 (28.3%) occurred in BRCA1, 16 (23.9%) in BRCA2, 7 (10.4%) in PALB2, 6 (9.0%) in TP53, 2 (3.0%) in PTEN, 2 (3.0%) in CDH1 and 15 (22.4%) in other predisposition genes. Notably, 47.8% of pathogenic variants were in non-BRCA1/2 genes. Of the 66 patients with pathogenic mutations, 63.6% (42/66) were under the age of 40 years. Family history of breast and/or ovarian cancer is enriched in patients with BRCA1/2 pathogenic variants but less predictive for non-BRCA1/2 related pathogenic variations. We detected a median of three variants of unknown significance (VUS) per gene (range 0-21). Custom gene panel testing is feasible and useful for the detection of pathogenic mutations and should be done in the setting of a formal clinical cancer genetics service given the rate of VUS.

SUBMITTER: Wong ESY 

PROVIDER: S-EPMC5685290 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature

altmetric image

Publications

Inherited breast cancer predisposition in Asians: multigene panel testing outcomes from Singapore.

Wong Edward S Y ESY   Shekar Sandhya S   Met-Domestici Marie M   Chan Claire C   Sze Melody M   Yap Yoon Sim YS   Rozen Steven G SG   Tan Min-Han MH   Ang Peter P   Ngeow Joanne J   Lee Ann S G ASG  

NPJ genomic medicine 20160113


Genetic testing for germline mutations in breast cancer predisposition genes can potentially identify individuals at a high risk of developing breast and/or ovarian cancer. There is a paucity of such mutational information for Asians. Panel testing of 25 cancer susceptibility genes and <i>BRCA1/2</i> deletion/duplication analysis was performed for 220 Asian breast cancer patients or their family members referred for genetics risk assessment. All 220 participants had at least one high-risk featur  ...[more]

Similar Datasets

| S-EPMC6769562 | biostudies-literature
| S-EPMC5599323 | biostudies-literature
| S-EPMC6093350 | biostudies-literature
| S-EPMC7540976 | biostudies-literature
| S-EPMC6360477 | biostudies-literature
| S-EPMC7820260 | biostudies-literature
| S-EPMC6614360 | biostudies-literature
| S-EPMC6157886 | biostudies-literature
| S-EPMC5410210 | biostudies-literature
| S-EPMC7326311 | biostudies-literature